Companies / Aclaris Therapeutics, Inc. / Activity
Activity — Aclaris Therapeutics, Inc.
69 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Kolbeck Roland Wilhelm Executive | Grant | Restricted Stock Units | — | +96K | 95,700 0.07% of shares | low |
| Feb 2, 2026 | Hall Jesse Wayne Executive | Grant | Employee Stock Option (Right to Buy) | — | +343K | 343,300 0.23% of shares | low |
| Feb 2, 2026 | Hall Jesse Wayne Executive | Grant | Restricted Stock Units | — | +98K | 98,100 0.07% of shares | low |
| Feb 2, 2026 | Davis Hugh M. Executive | Grant | Employee Stock Option (Right to Buy) | — | +336K | 336,300 0.23% of shares | low |
| Feb 2, 2026 | Davis Hugh M. Executive | Grant | Restricted Stock Units | — | +96K | 96,100 0.07% of shares | low |
| Feb 2, 2026 | Balthaser Kevin Executive | Grant | Employee Stock Option (Right to Buy) | — | +347K | 346,800 0.24% of shares | low |
| Feb 2, 2026 | Balthaser Kevin Executive | Grant | Restricted Stock Units | — | +99K | 99,100 0.07% of shares | low |
| Feb 3, 2026 | Davis Hugh M. Executive | Exercise | Restricted Stock Units | — | -19K -25.00% | 56,025 0.04% of shares | low |
| Feb 3, 2026 | Davis Hugh M. Executive | Exercise | Common Stock | — | +19K +69.81% | 45,425 0.03% of shares | low |
| Feb 3, 2026 | Balthaser Kevin Executive | Exercise | Restricted Stock Units | — | -22K -25.00% | 66,075 0.04% of shares | low |
| Feb 3, 2026 | Balthaser Kevin Executive | Exercise | Common Stock | — | +22K +12.94% | 192,204 0.13% of shares | low |
| Feb 1, 2026 | Balthaser Kevin Executive | Exercise | Restricted Stock Units | — | -15K -33.33% | 29,500 0.02% of shares | low |
| Feb 1, 2026 | Balthaser Kevin Executive | Exercise | Common Stock | — | +15K +9.20% | 175,163 0.12% of shares | low |
| Jan 2, 2026 | Balthaser Kevin Executive | Exercise | Restricted Stock Units | — | -13K -49.25% | 13,600 <0.01% of shares | low |
| Jan 1, 2026 | Balthaser Kevin Executive | Exercise | Restricted Stock Units | — | -8K -50.00% | 7,500 <0.01% of shares | low |
| Dec 31, 2025 | Balthaser Kevin Executive | Exercise | Restricted Stock Units | — | -74K -100.00% | 0 0.00% of shares | low |
| Jan 2, 2026 | Balthaser Kevin Executive | Exercise | Common Stock | — | +13K +8.70% | 164,874 0.11% of shares | low |
| Jan 1, 2026 | Balthaser Kevin Executive | Exercise | Common Stock | — | +8K +5.12% | 153,924 0.10% of shares | low |
| Dec 31, 2025 | Balthaser Kevin Executive | Exercise | Common Stock | — | +74K +79.64% | 166,358 0.11% of shares | low |